Jacobio Pharmaceuticals Group Co., Ltd. (01167) disclosed in its monthly return for the period ended 31 October 2025 that its authorized share capital remained at 1,000,000,000 ordinary shares, with a par value of USD 0.0001 per share. The total authorized share capital was unchanged at USD 100,000.

As of 31 October 2025, the total number of issued shares stood at 791,755,080, comprising 787,543,980 issued shares (excluding treasury shares) and 4,211,100 treasury shares. During the reporting month, 864,900 shares were repurchased and added to treasury at various share prices, leading to a corresponding decrease of 864,900 in the issued shares (excluding treasury shares). The repurchases took place between 17 October 2025 and 30 October 2025, at prices ranging from HKD 7.11 to HKD 7.91.

No other share options, warrants, or convertible securities were reported for the period, and no other changes in issued shares were disclosed. The director under whose authority this summary was submitted is noted as Xiaojie WANG.